NDC 51662-1248
PROMETHAZINE HCI
Promethazine Hci
PROMETHAZINE HCI is a Intramuscular; Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co. Llc, Dba Healthfirst. The primary component is Promethazine Hydrochloride.
| Product ID | 51662-1248_744bcc7b-a1b4-1b72-e053-2a91aa0a7c3a |
| NDC | 51662-1248 |
| Product Type | Human Prescription Drug |
| Proprietary Name | PROMETHAZINE HCI |
| Generic Name | Promethazine Hci |
| Dosage Form | Injection |
| Route of Administration | INTRAMUSCULAR; INTRAVENOUS |
| Marketing Start Date | 2018-08-26 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA083312 |
| Labeler Name | HF Acquisition Co. LLC, DBA HealthFirst |
| Substance Name | PROMETHAZINE HYDROCHLORIDE |
| Active Ingredient Strength | 50 mg/mL |
| Pharm Classes | Phenothiazine [EPC],Phenothiazines [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |